Please wait while the formulary information is being retrieved.
CONJUPRI (levamlodipine maleate)
- high blood pressure
2.5 mg tablet
- 1 tablet (2.5 mg) by oral route once daily
5 mg tablet
- 1 tablet (5 mg) by oral route once daily
Default screening record
- 2 tablets (5 mg) by oral route once daily
- 1 tablet (5 mg) by oral route once daily
- one-half tablet (1.25 mg) by oral route once daily
- one-half tablet (2.5 mg) by oral route once daily
- 1 tablet (2.5 mg) by oral route once daily
- ezetimibe-simvastatin
- Vytorin 10-40
- Vytorin 10-80
Contraindicated
- amoxicil-clarithromy-lansopraz
- Biaxin
- Biaxin Xl
- Biaxin Xl Pak
- clarithromycin
- conivaptan in 5 % dextrose
- Dantrium
- dantrolene
- Erythrocin
- erythromycin
- erythromycin-sulfisoxazole
- Ketek
- Omeclamox-pak
- omeprazole-clarith-amoxicillin
- Prevpac
- Revonto
- telithromycin
- Vaprisol
Severe
Moderate
- Astagraf Xl
- boceprevir
- cyclosporine
- cyclosporine modified
- Gengraf
- Hecoria
- Incivek
- isoniazid-rifamp-pyrazinamide
- Juxtapid
- ketoconazole
- lomitapide
- Mycobutin
- Neoral
- niacin-simvastatin
- Priftin
- Prograf
- rifabutin
- Rifadin
- Rifamate
- rifampin
- rifampin-isoniazid
- rifapentine
- Rifater
- Sandimmune
- Simcor
- simvastatin
- tacrolimus
- telaprevir
- Victrelis
- Vytorin 10-10
- Vytorin 10-20
- Zocor
- None
Contraindicated
- Severe aortic valve stenosis
- Severe hepatic disease
- Severe hypotension
Severe
Moderate
- None
CONJUPRI (levamlodipine maleate)
- high blood pressure
- None
- Acute abdominal pain
- Drowsy
- Edema
- Headache disorder
- Nausea
- Peripheral edema
More Frequent
Severe
Less Severe
- None
- Dizziness
- Fatigue
- Flushing
- Palpitations
Less Frequent
Severe
Less Severe
Rare / Very Rare
Severe
- Abnormal hepatic function tests
- Acute myocardial infarction
- Angioedema
- Atrial fibrillation
- Bradycardia
- Depersonalization
- Depression
- Erythema multiforme
- Extrapyramidal disease
- Hypotension
- Jaundice
- Leukopenia
- Pancreatitis
- Progressive angina pectoris
- Pulmonary edema
- Purpura
- Thrombocytopenic disorder
- Ventricular tachycardia
Less Severe
- Abnormal sexual function
- Anorexia
- Arthralgia
- Back pain
- Chest pain
- Chills
- Conjunctivitis
- Constipation
- Cramps
- Diarrhea
- Dream disorder
- Drug-induced hot flash
- Dysphagia
- Dyspnea
- Epistaxis
- Flatulence
- General weakness
- Gingival hyperplasia
- Gynecomastia
- Hyperglycemia
- Hyperhidrosis
- Hypoesthesia
- Increased urinary frequency
- Insomnia
- Maculopapular rash
- Malaise
- Myalgia
- Nervousness
- Nocturia
- Ocular pain
- Osteoarthritis
- Paresthesia
- Peripheral ischemia
- Peripheral neuropathy
- Polydipsia
- Pruritus of skin
- Skin rash
- Symptoms of anxiety
- Syncope
- Tachycardia
- Tinnitus
- Tremor
- Vasculitis
- Vertigo
- Visual changes
- Vomiting
- Weight gain
- Weight loss
- Xerostomia
Contraindicated
None
Severe Precaution
None
Management or Monitoring Precaution
Amlodipine, Levamlodipine
No safety and efficacy data for age < 6 years.
- 1 Day – 6 Years
- No safety and efficacy data for age < 6 years.
Levamlodipine
- Severity Level:
2
- Additional Notes: Insufficient human data available on developmental toxicity risk.
Contraindicated
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Precaution Exists
Levamlodipine
Insufficient human data available
| General | Excretion Potential | Effect on Infant | Notes |
| Evaluate use carefully | Excreted | Not known; no or inclusive data | Insufficient human data available |
No Known Risk
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Contraindicated
None
Precaution Exists
Levamlodipine
General-Not recommended as first line therapy in the elderly. Cardiovascular-Start at 1.25 mg/day and slowly titrate upward. Peripheral edema may be common. Lower drug clearance may result in increased sensitivity to blood pressure lowering effects. Gastrointestinal-May cause or worsen pre-existing constipation.
| Organ / System | HEP | REN | CARD | ENDO | NEURO / PSYCH | PULM |
| Increased Risk / Adverse Effects | N | Y | Y | N | N | N |
BEERS: N HEDIS: N STOPP: Y
No Known Risk
None
- None
| Hypertension | |
| I10 | Essential (primary) hypertension |
| I11 | Hypertensive heart disease |
| I11.0 | Hypertensive heart disease with heart failure |
| I11.9 | Hypertensive heart disease without heart failure |
| I12 | Hypertensive chronic kidney disease |
| I12.0 | Hypertensive chronic kidney disease with stage 5 chronic kidney disease or end stage renal disease |
| I12.9 | Hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease |
| I13 | Hypertensive heart and chronic kidney disease |
| I13.0 | Hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease |
| I13.1 | Hypertensive heart and chronic kidney disease without heart failure |
| I13.10 | Hypertensive heart and chronic kidney disease without heart failure, with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease |
| I13.11 | Hypertensive heart and chronic kidney disease without heart failure, with stage 5 chronic kidney disease, or end stage renal disease |
| I13.2 | Hypertensive heart and chronic kidney disease with heart failure and with stage 5 chronic kidney disease, or end stage renal disease |
| I15.1 | Hypertension secondary to other renal disorders |
| 0-9 | A-Z |
|---|---|
| I10 | Essential (primary) hypertension |
| I11 | Hypertensive heart disease |
| I11.0 | Hypertensive heart disease with heart failure |
| I11.9 | Hypertensive heart disease without heart failure |
| I12 | Hypertensive chronic kidney disease |
| I12.0 | Hypertensive chronic kidney disease with stage 5 chronic kidney disease or end stage renal disease |
| I12.9 | Hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease |
| I13 | Hypertensive heart and chronic kidney disease |
| I13.0 | Hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease |
| I13.1 | Hypertensive heart and chronic kidney disease without heart failure |
| I13.10 | Hypertensive heart and chronic kidney disease without heart failure, with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease |
| I13.11 | Hypertensive heart and chronic kidney disease without heart failure, with stage 5 chronic kidney disease, or end stage renal disease |
| I13.2 | Hypertensive heart and chronic kidney disease with heart failure and with stage 5 chronic kidney disease, or end stage renal disease |
| I15.1 | Hypertension secondary to other renal disorders |
Formulary Reference Tool